LifeStance Health (LFST) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for LifeStance Health (LFST) over the last 5 years, with Q2 2025 value amounting to -$0.01.
- LifeStance Health's EPS (Weighted Average and Diluted) rose 8333.33% to -$0.01 in Q2 2025 from the same period last year, while for Sep 2025 it was -$0.03, marking a year-over-year increase of 8846.15%. This contributed to the annual value of -$0.15 for FY2024, which is 7029.3% up from last year.
- As of Q2 2025, LifeStance Health's EPS (Weighted Average and Diluted) stood at -$0.01, which was up 8333.33% from -$0.02 recorded in Q4 2024.
- In the past 5 years, LifeStance Health's EPS (Weighted Average and Diluted) ranged from a high of -$0.01 in Q2 2025 and a low of -$329.84 during Q4 2021
- Its 5-year average for EPS (Weighted Average and Diluted) is -$22.09, with a median of -$0.12 in 2023.
- As far as peak fluctuations go, LifeStance Health's EPS (Weighted Average and Diluted) soared by 9996.06% in 2022, and later crashed by 5454.55% in 2023.
- Over the past 5 years, LifeStance Health's EPS (Weighted Average and Diluted) (Quarter) stood at -$329.84 in 2021, then surged by 99.96% to -$0.13 in 2022, then rose by 7.69% to -$0.12 in 2023, then surged by 84.37% to -$0.02 in 2024, then surged by 46.69% to -$0.01 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.01 for Q2 2025, versus -$0.02 for Q4 2024 and -$0.02 for Q3 2024.